BLUEPRINT MEDICINES CORP (BPMC)
US09627Y1091 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 180.1M -77.31% | 204M 13.27% | 249.38M 22.25% | 518.93M 108.09% | 723.08M 39.34% | 961.89M 33.03% | 1.198B 24.55% | 1.357B 13.27% | 1.599B 17.83% | 1.858B 16.20% | 2.305B 24.06% | |
| EBITDA YoY % growth | -635.5M -301.55% | -525.8M 17.26% | -474.612M 9.74% | -204.096M 57.00% | -41.163M 79.83% | 139.42M 438.70% | 233.4M 67.41% | 347M 48.67% | 458.02M 31.99% | 580.62M 26.77% | N/A | |
| EBIT YoY % growth | -642M -307.97% | -537.5M 16.28% | -486.277M 9.53% | -207.66M 57.30% | -48.001M 76.88% | 147.28M 406.83% | 319.14M 116.69% | 469.76M 47.20% | 595.05M 26.67% | 831.23M 39.69% | 1.292B 55.43% | |
| Operating Margin | -356.47% | -263.48% | -194.99% | -40.02% | -6.64% | 15.31% | 26.64% | 34.62% | 37.21% | 44.74% | 56.05% | |
| EPS YoY % growth | -10.92 -308.40% | -9.35 14.38% | -8.36 10.59% | -1.00 88.00% | -0.96 4.42% | 1.62 268.73% | 4.74 192.73% | 9.21 94.40% | 8.87 -3.73% | 10.50 18.40% | 22.60 115.29% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.71 60.90% | -0.63 52.36% | -0.49 38.90% | -0.31 64.88% | -0.10 85.39% |
| Revenue Q2Q % growth | 148.88M 106.90% | 159.45M 65.89% | 172.85M 25.11% | 186.49M 45.49% | 200.9M 34.94% |
| EBITDA Q2Q % growth | -37.577M 59.79% | -13.862M 81.27% | -1.571M 95.46% | 10.251M 127.94% | 18.88M 150.24% |
| EBIT Q2Q % growth | -38.505M 63.37% | -29.041M 63.16% | -19.473M 54.76% | -7.955M 83.76% | 3.629M 109.42% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.89 59.55% | -0.99 | 0.10 | 9.73% |
| Q2 2024 Q2Q % growth | -0.80 63.47% | -1.32 | 0.52 | 39.24% |
| Q1 2024 Q2Q % growth | -1.32 38.60% | -1.70 | 0.38 | 22.15% |
| Q4 2023 Q2Q % growth | -1.82 31.32% | -2.08 | 0.26 | 12.53% |
| Q3 2023 Q2Q % growth | -2.20 1.35% | -2.41 | 0.21 | 8.88% |
| Q2 2023 Q2Q % growth | -2.19 18.28% | -2.59 | 0.40 | 15.46% |
| Q1 2023 Q2Q % growth | -2.15 -20.11% | -2.72 | 0.57 | 21.05% |
| Q4 2022 Q2Q % growth | -2.65 50.93% | -2.70 | 0.05 | 1.95% |
| Q3 2022 Q2Q % growth | -2.23 -14.95% | -2.54 | 0.31 | 12.08% |
| Q2 2022 Q2Q % growth | -2.68 -44.09% | -2.27 | -0.41 | -17.97% |
| Q1 2022 Q2Q % growth | -1.79 -4.07% | -1.90 | 0.11 | 5.83% |
| Q4 2021 Q2Q % growth | -5.40 -252.94% | -1.68 | -3.72 | -221.69% |
| Q3 2021 Q2Q % growth | -1.94 -117.38% | -1.66 | -0.28 | -16.74% |
| Q2 2021 Q2Q % growth | -1.86 18.42% | -1.90 | 0.04 | 1.91% |
| Q1 2021 Q2Q % growth | -1.72 18.48% | -1.91 | 0.19 | 9.77% |
| Q4 2020 Q2Q % growth | -1.53 -13.33% | -1.66 | 0.13 | 7.64% |
| Q3 2020 Q2Q % growth | 11.16 678.24% | 7.87 | 3.29 | 41.79% |
| Q2 2020 Q2Q % growth | -2.28 -11.76% | -2.18 | -0.10 | -4.59% |
| Q1 2020 Q2Q % growth | -2.11 -6.57% | -2.12 | 0.01 | 0.44% |
| Q4 2019 Q2Q % growth | -1.35 | -1.73 | 0.38 | 21.89% |
| Q3 2019 Q2Q % growth | -1.93 | -2.22 | 0.29 | 13.09% |
| Q2 2019 Q2Q % growth | -2.04 | -1.94 | -0.10 | -4.92% |
| Q1 2019 Q2Q % growth | -1.98 | -1.90 | -0.08 | -4.46% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 128.184M 126.61% | 129.57M | -1.386M | -1.07% |
| Q2 2024 Q2Q % growth | 138.157M 139.98% | 105.65M | 32.507M | 30.77% |
| Q1 2024 Q2Q % growth | 96.116M 51.87% | 82.043M | 14.073M | 17.15% |
| Q4 2023 Q2Q % growth | 71.957M 85.46% | 67.61M | 4.347M | 6.43% |
| Q3 2023 Q2Q % growth | 56.566M -14.29% | 51.407M | 5.159M | 10.04% |
| Q2 2023 Q2Q % growth | 57.57M 57.73% | 46.375M | 11.195M | 24.14% |
| Q1 2023 Q2Q % growth | 63.287M 0.94% | 42.795M | 20.492M | 47.88% |
| Q4 2022 Q2Q % growth | 38.8M -63.74% | 35.124M | 3.676M | 10.47% |
| Q3 2022 Q2Q % growth | 66M 172.73% | 44.287M | 21.713M | 49.03% |
| Q2 2022 Q2Q % growth | 36.5M 33.70% | 37.988M | -1.488M | -3.92% |
| Q1 2022 Q2Q % growth | 62.7M 190.28% | 39.443M | 23.257M | 58.96% |
| Q4 2021 Q2Q % growth | 107M 213.78% | 104.74M | 2.26M | 2.16% |
| Q3 2021 Q2Q % growth | 24.2M -96.75% | 43.32M | -19.12M | -44.14% |
| Q2 2021 Q2Q % growth | 27.3M 228.92% | 19.542M | 7.758M | 39.70% |
| Q1 2021 Q2Q % growth | 21.6M 248.39% | 17.591M | 4.009M | 22.79% |
| Q4 2020 Q2Q % growth | 34.1M -33.79% | 29.825M | 4.275M | 14.33% |
| Q3 2020 Q2Q % growth | 745.1M 8,087.91% | 644.2M | 100.9M | 15.66% |
| Q2 2020 Q2Q % growth | 8.3M 62.75% | 7.08M | 1.22M | 17.23% |
| Q1 2020 Q2Q % growth | 6.2M 785.71% | 5.124M | 1.076M | 21.00% |
| Q4 2019 Q2Q % growth | 51.5M | 26.597M | 24.903M | 93.63% |
| Q3 2019 Q2Q % growth | 9.1M | 2.639M | 6.461M | 244.83% |
| Q2 2019 Q2Q % growth | 5.1M | 2.018M | 3.082M | 152.73% |
| Q1 2019 Q2Q % growth | 700K | 1.734M | -1.034M | -59.63% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 36.17% | -0.53% | 23.43% |
| Revenue | 0% | 21.64% | 0% | 2.76% |